Hamariweb

Vasoactive Intestinal Peptide: Emerging Research Perspectives

Vasoactive Intestinal Peptide (VIP) has remained a molecule of considerable scientific interest since its initial ...

MediBeacon® Next Generation TGFR™ System Receives FDA Approval

MediBeacon® TGFRTM System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence ...

Invest Green Acquisition Corporation Announces the Separate Trading of Its Class A Ordinary Shares and Rights, Commencing on December 22, 2025

Invest Green Acquisition Corporation (Nasdaq: IGACU) (the “Company”) today announced that, commencing on December 22, 2025, holders of the units (the “Units”) sold in the Company’s initial public ...
Le Lézard

Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing ...

Vir Biotechnology, Inc. today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive license for ...